BATF3 and gastroenteritis: Previous studies using Batf3-/- mice did not observe any spontaneous development of intestinal inflammation or increased susceptibly to DSS colitis which is consistent with our findings in 8- and 16-week-old Batf3-/- mice (43) (Figures S3C, D).